Daily news email for July 30, 2012 | Click here for updated news
BioSpace - Breaking News
Alnylam Pharmaceuticals Earns $3.2 Million Milestone Payment From GlaxoSmithKline in VaxiRNA Collaboration on Flu Vaccine Production
Endovascular Therapy May Result in Significantly Better Outcomes Than Current Standard Treatment for Deadliest Strokes, Study
New Published Paper Shows Efficacy of Lpath, Inc.'s Anti-LPA Antibody, Lpathomab, in Spinal Cord Injury Models
Eisai Inc. and Arena Pharmaceuticals, Inc. Complete Transfer of BELVIQ® (lorcaserin HCl) New Drug Application
Merck & Co., Inc. Net Income Declines by 11% to $1,793 Million in Q2
|
Biotech News - Business Wire
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for RFID Asset Tracking and Management Solutions
SORIN GROUP REPORTS SECOND QUARTER 2012 RESULTS
SORIN GROUP ANNUNCIA I DATI DEL SECONDO TRIMESTRE 2012
ACT Treats 10th Patient in Embryonic Stem Cell Trials for Macular Degeneration
Supersonic Imagine anuncia la producción de su 500º ecógrafo Aixplorer® en el mundo
|
Biotech News - PR Newswire
Hyland Software hosts annual user forum for ECM, EMR software
Bio-Solutions Corp Begins Production of the Type2 Defense. Pursuing $25 Billion plus Type II and Pre-Diabetic Marketplace
Oncobiologics, Inc. Announces a Collaboration Agreement with XOMA Corporation to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform
Overcoming Challenges in Amblyopia Detection using Visual Evoked Potential (VEP)
Elsevier/DirectCourse Curriculum Aligns with APSE Certification Process
|
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
India Preparing to Introduce Price Controls
Amarin Wins FDA Approval of Vascepa
Hyperion Therapeutics Goes Public
Supreme Court Ruling on Healthcare Reform Will Lower Costs
California's Stem Cell Agency Approves $150 Million Grants
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
New York Times- Pharmaceuticals
Imagine a World Without AIDS
Helping Patients in Need
The Long, Uphill Battle Against AIDS
Baldness Battle, Fought in the Follicle
For Big Drug Companies, a Headache Looms
|
OnBioVC
Stemgent, Inc.: Series C $6.3M
Genalyte, Inc.: Series A $11.8M
Relievant Medsystems, Inc.: Series D $30M
ImaginAb, Inc.: Series A $12.5M
BiO2 Medical, Inc.: Series B $13.7M
|
Outsourcing-Pharma
Wockhardt targets CMO space for diversification
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles
Home visits = regulatory thumbs up ResearchNurses.co thinks so
Home visits are the key to patient retention, says ResearchNurses.co
Kemwell and Boehringer set to finish biologics plant in India
|
